An additional peril of pathologic complete response
Pathological complete response (pCR) has been shown to predict long-term outcomes in breast cancer patients undergoing primary systemic therapy in aggressive early breast cancer. Herein we discuss the caveats of determining pCR, and data needed to tailor breast cancer radiation after pCR.
Authors
- Philip Poortmans (ORCID: https://orcid.org/0000-0001-7400-2293)
- Trine Tramm (ORCID: https://orcid.org/0000-0003-3894-4552)
- Orit Kaidar‐Person (ORCID: https://orcid.org/0000-0003-4023-1869)
- Icro Meattini
Institutions
- University of Antwerp (BE)
- Sheba Medical Center (IL)
- Aarhus University Hospital (DK)
- Azienda Ospedaliero-Universitaria Careggi (IT)
- Iridium Kankernetwerk (BE)
Publication Details
- Journal
- Radiotherapy and Oncology
- Published
- 2025-05-27
- DOI
- https://doi.org/10.1016/j.radonc.2025.110962
- Citations
- 1
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.94